Statistics for RBD-specific polyclonal F(ab´)(2) fragments of equine antibodies in patients with moderate to severe COVID-19 disease: A randomized, multicenter, double-blind, placebo-controlled, adaptive phase 2/3 clinical trial
Total visits
views | |
---|---|
RBD-specific polyclonal F(ab´)(2) fragments of equine antibodies in patients with moderate to severe COVID-19 disease: A randomized, multicenter, double-blind, placebo-controlled, adaptive phase 2/3 clinical trial | 4 |
Total visits per month
views | |
---|---|
octubre 2024 | 0 |
noviembre 2024 | 0 |
diciembre 2024 | 0 |
enero 2025 | 0 |
febrero 2025 | 0 |
marzo 2025 | 1 |
abril 2025 | 0 |
File Visits
views | |
---|---|
j.eclinm.2021.100843 .pdf | 4 |
mmc1.docx | 3 |